open access

Ahead of print
Research Letter
Published online: 2021-02-16
Get Citation

Cardiovascular comorbidity and death from COVID-19: Prevalence and differential characteristics

Julia Playán-Escribano, Zaira Gómez-Álvarez, Teresa Romero-Delgado, Carlos Nicolás Pérez-García, Daniel Enríquez-Vázquez, Isidre Vilacosta
DOI: 10.5603/CJ.a2021.0023
·
Pubmed: 33634840

open access

Ahead of print
Research letter
Published online: 2021-02-16

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

COVID-19; SARS-CoV-2; myocardial injury

About this article
Title

Cardiovascular comorbidity and death from COVID-19: Prevalence and differential characteristics

Journal

Cardiology Journal

Issue

Ahead of print

Article type

Research Letter

Published online

2021-02-16

DOI

10.5603/CJ.a2021.0023

Pubmed

33634840

Keywords

COVID-19
SARS-CoV-2
myocardial injury

Authors

Julia Playán-Escribano
Zaira Gómez-Álvarez
Teresa Romero-Delgado
Carlos Nicolás Pérez-García
Daniel Enríquez-Vázquez
Isidre Vilacosta

References (9)
  1. Ministerio de Sanidad, Consumo y Bienestar Social. Actualización nº 258. Enfermedad por el coronavirus (COVID-19). 2020. https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_135_COVID-19.pdf (Accessed November 26th 2020).
  2. European Society of Cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. 2020. https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance (Accessed November 26th 2020).
  3. Kowalik MM, Trzonkowski P, Łasińska-Kowara M, et al. COVID-19 - Toward a comprehensive understanding of the disease. Cardiol J. 2020; 27(2): 99–114.
  4. Gąsecka A, Filipiak KJ, Jaguszewski MJ. Impaired microcirculation function in COVID-19 and implications for potential therapies. Cardiol J. 2020; 27(5): 485–488.
  5. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009; 64 Suppl 3: iii1–ii55.
  6. Onder G, Rezza G, Brusaferro S. Case-Fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020; 323(18): 1775–1776.
  7. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020; 58(7): 1131–1134.
  8. Lorente-Ros A, Monteagudo Ruiz JM, Rincón LM, et al. Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients. Cardiol J. 2020; 27(5): 489–496.
  9. Kim JS, Kim M, Kim YJ, et al. Troponin testing for assessing sepsis-induced myocardial dysfunction in patients with septic shock. J Clin Med. 2019; 8(2).

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl